1,3-Diphenylpropan-2-amine hydrochloride, 95.0%, 1g

(E)-2-Cyano-3-(4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indol-7-yl)acrylic acid, 98+%, 50mg

1-Benzyl-7-bromo-1H-indazole, 97%, 1g

(3-(Pyrrolidine-1-carbonyl)phenyl)boronic acid, 98%, 25g

2-Bromo-N-methylpyridin-4-amine, 95.0%, 250mg

2-(3-((3-Chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 100mg

N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide, 98%, 100mg

4-Bromo-3-fluorobenzonitrile>98.0%(GC)25g

3-Indoxyl-beta-D-glucopyranoside, min. 99%, for biochemistry, 1 g, glass packaging

4-N-Butoxyphenylboronic acid, 95.0%, 1g

Methyl 3-(benzyloxy)-5-hydroxybenzoate, 95.0%, 1g

{[(4-bromo-2-fluorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 10g

2,2'-(cyclohexa-2,5-diene-1,4-diylidene)dimalononitrile compound with 2,2'-bi(1,3-dithiolylidene) (1:1), 95%, 1g